|
Efficacy of treatment |
||||||
| Effectiveness on the basis of increase of dosage |
Relapse on the basis of decrease of dosage |
Improvement of symptoms |
||||
|
|
||||||
| Fever |
Rigor |
Both |
Not mentioned |
|||
|
|
||||||
| Dantrolene monotherapy |
2/37 (5.4%) |
3/37 (8.1%) |
9 (24.3%) |
4 (10.8%) |
9 (24.3%) |
15 (40.5%) |
| Dantrolene with additive medication |
5/82 (6.1%) |
7/82 (8.5%) |
10 (12.2%) |
3 (3.7%) |
12 (14.6%) |
57 (69.5%) |
| Other medication |
4/101 (4.0%) |
17/101 (16.8%) |
12 (11.9%) |
2 (2.0%) |
14 (13.9%) |
73 (72.3%) |
| Only supportive therapy |
Not applicable |
Not applicable |
1 (2.0%) |
- |
1 (2.0%) |
49 (96.1%) |
Reulbach et al. Critical Care 2007 11:R4 doi:10.1186/cc5148 |
||||||